Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
1936
Pahwa S, Chavan AG, Jain R and Roy N. Target-specific anti-fungal discovery by targeting Geotrichum candidum histidinol dehydrogenase: a hybrid approach Chemical Biology & Drug Design 2008, 72, 229-234.
1937
Panchagnula R and Bharadwaj V. Effect of amorphous content on dissolution characteristics of rifampicin Drug Development and Industrial Pharmacy 2008, 34, 642-649.
1938
Patel DS and Bharatam PV. Selectivity criterion for pyrazolo[3,4-b]pyrid[az]ine derivatives as GSK-3 inhibitors: CoMFA and molecular docking studies European Journal of Medicinal Chemistry 2008, 43, 949-957.
1939
Patel S, Kaushal AM and Bansal AK. Compaction behavior of roller compacted ibuprofen European Journal of Pharmaceutics and Biopharmaceutics 2008, 69, 743-749.
1940
Pathan AR, Gaikwad AB, Viswanad B and Ramarao P. Rosiglitazone attenuates the cognitive deficits induced by high fat diet feeding in rats European Journal of Pharmacology 2008, 589, 176-179.
1941
Patil PR and Kartha KPR. Application of Ball Milling Technology to Carbohydrate Reactions: I Regioselective Primary Hydroxyl Protection of Hexosides and Nucleoside by Planetary Ball Milling Journal of Carbohydrate Chemistry 2008, 27, 279-293.
1942
Patil PR and Kartha KPR. Solvent-Free Mechanochemical Synthesis of Aryl Glycosides Journal of Carbohydrate Chemistry 2008, 27, 411-419.
1943
Paul AT, Vir S and Bhutani KK. Liquid chromatography - mass spectrometry-based quantification of steroidal glycoalkaloids from Solanum xanthocarpum and effect of different extraction methods on their content Journal of Chromatography A 2008, 1208, 141-146.
1944
Paul M K, Kumar R and Mukhopadhyay AK. Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells Toxicology and Applied Pharmacology 2008, 226, 140-152.
1945
Prasad B, Kumar V, Bhutani H and Singh S. Screening of bulk drug samples and anti-tuberculosis products for the presence of therapeutically less active diasteriometric(R,S) form of ethambutol dihydrochloride Indian Journal of Tuberculosis 2008, 55, 192-198.
1946
Prusty D, Mehra P, Srivastava S, Shivange A, Gupta A, Roy N and Dhar S. Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth FEMS Microbiology Letters 2008, 282, 266-272.
1947
Rai D, Singh JK, Roy N and Panda D. Curcumin inhibits FtsZ assembly and increases GTPase activity of FtsZ: An attractive mechanism for its antibacterial activity Biochemical Journal 2008, 410, 147-155.
1948
Rathore R, Jain JP, Srivastava A, Jachak SM and Kumar N. Simultaneous determination of hydrazinocurcumin and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation Journal of Pharmaceutical and Biomedical Analysis 2008, 46, 374-380.
1949
Ratnam DV, Chandraiah G, Sonaje K, Viswanad B and Bhardwaj V, Ramarao P and Ravi Kumar MNV. A potential therapeutic strategy for diabetes and its complications in the form of co-encapsulated antioxidant nanoparticles (NanoCAPs) of ellagic acid and coenzyme Q10: Preparation and evaluation in streptozotocin induced diabetic rats Journal of Biomedical Nanotechnology 2008, 4, 33-43.
1950
Sahana D, Mittal G, Bhardwaj V and Ravi Kumar MNV. PLGA Nanoparticles for oral administration of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug Journal of Pharmaceutical Sciences 2008, 97, 1530-1542.
1951
Sarkar M, Perumal OP and Panchagnula R. Solid-state characterization of nevirapine Indian Journal of Pharmaceutical Sciences 2008, 70, 619-630.
1952
Shah D, Khandavilli S and Panchagnula R. Alteration of skin hydration and its barrier function by vehicles: A study using TGA, FTIR, TEWL and amphiphillic drug molecule as marker Methods and Findings in Experimental and Clinical Pharmacology 2008, 30, 499-512.
1953
Shah P, Mittal A and Bharatam PV. CoMFA analysis of dual/multiple PPAR activators European Journal of Medicinal Chemistry 2008, 43, 2784-2791.
1954
Shah RP, Kumar V and Singh S. LC and LC-MS studies on Atorvastatin and its stress degradation products Rapid Communications in Mass Spectrometry 2008, 22, 613-622.
1955
Shaikh MS, Mittal A and Bharatam PV. Design of Fructose-2,6-Bisphosphatase Inhibitors: A novel Virtual Screening Approach Journal of Molecular Graphics and Modelling 2008, 26, 900-906.
1956
Sharma A, Dadwal SS and Mahal SS. Why hospitals also need benchmarking Marketing Capabilities? An empirical study of relationships between marketing practices and its outcomes Paradigm 2008, 12, 77-88.
1957
Sharma G, Kumar R and Chakraborti AK. Fluoroboric Acid Adsorbed on Silica-gel as a New, Highly Efficient and Reusable Heterogeneous Catalyst for Thia-Michael Addition to α,β-Unsaturated Carbonyl Compounds Tetrahedron Letters 2008, 49, 4272-4275.
1958
Sharma G, Kumar R and Chakraborti AK. On Water' Synthesis of 2,4-Diaryl-2,3-dihydro-1,5-benzothiazepines Catalysed by Sodium Dodecyl Sulphate (SDS) Tetrahedron Letters 2008, 49, 4269-4271.
1959
Sharma SS, Kaundal R and Kumar A. Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy Life Sciences 2008, 82, 570-576.
1960
Singh GM, Chavan HD and Dey CS. Proteomic analysis of miltefosine resistant Leishmania reveals the possible involvement of eukaryotic initiation factor 4A, eIF4A International Journal of Antimicrobial Agents 2008, .
1961
Singh M, Singh S, Singh RS, Chisti, Y and Banerjee UC. Transesterification of primary and secondary alcohols using Pseudomonas aeruginosa lipase Bioresource Technology 2008, 99, 2116-2120.
1962
Singh N, Dhanaraj, Tiwari P and Anil Bhansali. Attainment of target blood pressure and patterns of antihypertensive therapy in type 2 diabetic hypertensive Asian Indians International Journal of Risk & Safety in Medicine 2008, 20, 45-50.
1963
Singh RP, Singh JS and Singh PP. Effects of morphine during Mycobacterium tuberculosis H37Rv infection in mice Life Sciences 2008, 82, 308-314.
1964
Sobhia ME and Nair PC. Comparative QSTR studies for predicting mutagenicity of nitro compounds Journal of Molecular Graphics and Modelling 2008, 26, 916-934.
1965
Sobhia ME, Srikanth K and Nair PC. Probing the Structural and Topological Requirements for CCR2 antagonism: Holographic QSAR for indolopiperidine derivatives Bioorganic & Medicinal Chemistry Letters 2008, 18, 1450-1456.
1966
Sokolsky-Papkov M, Shikanov A, Kumar N, Vaisman B and Domb AJ. 83); Fatty acid based biodegradable polymers-synthesis and applications Bulletin of the Israel Chemical Society 2008, 23, 17-12.
1967
Soni P, Kansal H and Banerjee UC. Optimization of process parameters for the production of carbonyl reductase by Candida viswanathii in a laboratory-scale fermenter Journal of Industrial Microbiology and Biotechnology 2008, 35, 167-173.
1968
Sreedhar S and Sharma SS. Protective effect of adenosine in diabetic neuropathic pain is mediated through adenosine a1 receptors Indian Journal of Physiology and Pharmacology 2008, 52, 233-242.
1969
Sundriyal S, Bharathy E, Viswanand B, Ramarao P, Chakraborti AK and Bharatam PV. New PPARg ligands based on 2-hydroxy-1,4-naphthoquinone: Computer aided design, synthesis and receptor binding studies Bioorganic & Medicinal Chemistry Letters 2008, 18, 3192-3195.
1970
Sundriyal S, Khanna S, Saha R and Bharatam PV. Metformin and glitazones: does similarity in biomolecular mechanism originate from tautomerism in these drugs? Journal of Physical Organic Chemistry 2008, 21, 30-33.
1971
Sundriyal S, Sharma RK, Jain R and Bhartam PV. Minimum requirement of hydrophobic and hydrophilic features in cationic peptide antibiotics (CPAs): Pharmacophore generation and its validation on cationic steroid antibiotics (CSAs) Journal of Molecular Modeling 2008, 14, 265-278.
1972
Sundriyal S, Viswanad B, Ramarao P, Chakraborti AK and Bharatam PV. New PPARg ligands based on barbituric acid: Virtual Screening, synthesis and receptor binding studies Bioorganic & Medicinal Chemistry Letters 2008, 18, 4959-4962.
1973
Tekewe A, Singh S, Singh M and Banerjee UC. Development and validation of HPLC method for the resolution of drug intermediates: DL-3-phenyllactic acid, DL-O-acetyl-3-phenyllactic acid and (±) mexiletine acetamide enantiomers Talanta 2008, 75, 239-245.
1974
Thanzami K and Roy I. A sensitive, rapid and specific technique for the detection of collagenase using zymography Electrophoresis 2008, 29, 1585-1588.
1975
Tikoo K, Meena RL, Kabra D, and Gaikwad AB. Change in post-translational modifications of histone H3, HSP-27 and p38 expression by curcumin in diabetic nephropathy British Journal of Pharmacology 2008, 153, 1225-1231.
1976
Tikoo K, Singh K, Kabra D, Sharma V and Gaikwad A. Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy Free Radical Research 2008, 42, 397-404.
1977
Tikoo K, Tamta A and Gaikwad AB. Tannic acid prevents Azidothymidine (AZT) induced hepatotoxicity and genotoxicity along with change in expression of PARG and histone H3 acetylation Toxicology Letters 2008, 177, 90-96.
1978
Tripathi DN and Jena GB. Astaxanthin Inhibits Cytotoxic and Genotoxic Effects of Cyclophosphamide in Mice Germ Cells Toxicology 2008, 248, 96-103.
1979
Tripathi DN and Jena GB. Ebselen attenuates cyclophosphamide induced oxidative stress and DNA damage in mice Free Radical Research 2008, 42, 966-977.
1980
Tripathi DN, Pawar AA, Vikram A, Ramarao P and Jena GB. Use of the alkaline comet assay for the detection of transplacental genotoxins in newborn mice Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2008, 653, 134-139.

Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|44|45